Иксазомиба цитрат - analogs
Components: Ixazomib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: — Instructions Иксазомиба цитрат | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Acidophilus 4x6 ✘ (incl) МОДЭЛЛЬ ПРО ✘ (incl) Гам-КОВИД-Вак-М Комбинированная векторная вакцина для профилактики коронавирусной инфекции, вызываемой вирусом SARS-СoV-2 ✘ (incl) Sarckolysin ✘ (incl) Ginseng ✘ (incl) Сироп солодки «Легкое дыхание» ✘ (incl) Комплекс экстрактов листьев красного винограда и гинкго билоба ✘ (incl) Бальзам безалкогольный «ХондроНорм» ✘ (incl) Гидрохлоротиазид+Лизиноприл ✘ (incl) Melandrium album ✘ (incl) Lansoptol ✘ (incl) Mitoxantron hydrochloride ✘ (incl) Тризенокс ✘ (incl) Бальзам «Бережем суставы» ✘ (incl) ISOTREXIN ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Ninlaro neutral | 2417.8€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 50% 1381.2€ Empliciti neutral [Elotuzumab]
- 42% 194.3-777.1€ Darzalex neutral [Daratumumab]
- 40% 788.9€ Kyprolis neutral [Carfilzomib]
- 33% — Pomalidomide-TL neutral [Pomalidomide]
- 33% — Иматанго neutral [Pomalidomide]
- 33% — Помалидомид neutral [Pomalidomide]
- 33% 6352.5-6726.4€ Imnovid neutral [Pomalidomide]
- 32% — Сарклиза neutral [Isatuximab]
- 31% — Nilotinib hydrochloride monohydrate neutral [Nilotinib]
- 31% 324.5€ Иглиб neutral [Imatinib]
- 31% 807.2-809.8€ Итулси neutral [Palbociclib]
- 31% 798-825€ Ibrance neutral [Palbociclib]
- 31% 1920€ Tasigna neutral [Nilotinib]
- 31% — Iimatinib mesilate neutral [Imatinib]
- 31% — Imatinib medac neutral [Imatinib]
- 31% — Imatinib-Alvogen neutral [Imatinib]
- 31% — Imagliv neutral [Imatinib]
- 31% — Citonib neutral [Imatinib]
- 31% — Nilotinib-nativ neutral [Nilotinib]
- 31% — Imatinib-Actavis neutral [Imatinib]
- 31% — Нилотиниб neutral [Nilotinib]
- 31% — Gistamel neutral [Imatinib]
- 30% 1732.5€ Lenvima neutral [Lenvatinib]
- 30% 992.7€ Talcenna neutral [Talazoparib]
- 27% 3936.6€ Кабометикс neutral [Cabozantinib]
- 24% — ANDRAXAN neutral
- 23% 271€ Neopax neutral [Imatinib]
- 23% — Imatinib-TL neutral [Imatinib]
- 22% — Imatinib-Teva neutral [Imatinib]
- 22% — Zykadia neutral [Ceritinib]
- 22% 637.5-902.1€ Giotrif neutral [Afatinib]
- 22% 5550€ Tagrisso neutral [Osimertinib]
- 22% — Imvec neutral [Imatinib]
- 22% — Imatinib Grindex neutral [Imatinib]
- 22% 605€ Imatib neutral [Imatinib]
- 22% — Глемихиб neutral [Imatinib]
- 22% — Осимертиниба мезилат neutral [Osimertinib]
- 22% — Цитонибонко neutral [Imatinib]
- 22% — Осимертиниб neutral [Osimertinib]
- 22% — Imatinib Dr. Reddy s neutral [Imatinib]
- 21% — Тироджин neutral [Thyrotropin alfa]
- 20% — Бендамустина гидрохлорид моногидрат neutral [Bendamustine]
- 20% — Egistrazol neutral [Anastrozole]
- 20% — Ковада neutral [Bendamustine]
- 20% 1274.7€ Tyverb neutral [Lapatinib]
- 20% 9.6-10.9€ Аназалес neutral [Anastrozole]
- 20% 2701.7-2704.5€ Xalkori neutral [Crizotinib]
- 20% — РОЗУСТИН neutral [Bendamustine]
- 20% 1199.1€ Risarg neutral [Ribociklib]
- 20% 11-11.6€ Anastrozole-Kabi neutral [Anastrozole]
Learn more about the selection of analogues
- The drug has «Иксазомиба цитрат» 1 full analog, the cheapest - Ninlaro (2417.8€); 51 analog by action, the most similar - Empliciti (1381.2€).
- Medical online service has selected the best substitutes for Иксазомиба цитрат based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Иксазомиба цитрат analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.